Dare Bioscience, Inc. (DARE) vs Vyome Holdings, Inc. (HIND)
A side-by-side comparison of Dare Bioscience, Inc. and Vyome Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DARE
Dare Bioscience, Inc.
$0.85HealthcareDelayed quote: Oct 6, 2026, 10:02 AM EDT
HIND
Vyome Holdings, Inc.
$1.92HealthcareDelayed quote: Oct 6, 2026, 10:02 AM EDT
Total return — DARE vs HIND
growth of $100 · dividends reinvested · last 10yDARE -99.3% (-39.1%/yr)HIND -100.0% (-84.2%/yr)DARE compounded faster over this window
Log scale — wide-divergence pair
DARE HIND
DARE vs HIND: by the numbers
- •HIND is the larger company ($13M vs $13M market cap).
- •Both run net losses; DARE's is the smaller (-804.37% vs -8716.77% net margin).
Metrics side by side
Valuation
| Metric | DARE | HIND |
|---|---|---|
| P/S ratio | 9.32 | 103.88 |
| P/B ratio | N/A | 2.23 |
| FCF yield | N/A | 3.89% |
Profitability
| Metric | DARE | HIND |
|---|---|---|
| Gross margin | -137.55% | 64.68% |
| Operating margin | -1315.51% | -859.22% |
| Net margin | -804.37% | -8716.77% |
| ROE | N/A | -186.95% |
| ROIC | -203.50% | -57.53% |
Growth (annualized)
| Metric | DARE | HIND |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -60.54% |
| Total return CAGR (5Y) | -46.35% | -92.93% |
Frequently asked
- How have DARE and HIND total returns compared?
- Over the past 5 years, DARE delivered -46.35% and HIND delivered -92.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.